Kokke
35 IP cases indexed. Covers patent matters.
Cases Presided Over
35 cases indexed | Page 2 of 2
Abbott Diabetes Care Inc. v.Sibio Technology Limited & Umedwings Netherlands B.V.
Abbott Diabetes Care Inc., proprietor of European patent EP2713879 relating to continuous glucose monitoring (CGM) on-body devices, sought a preliminary injunction against Sibio Technology Limited and Umedwings Netherlands B.V. for allegedly infringing the patent through the marketing of the GS1 CGM device in Europe. The Local Division The Hague granted the preliminary injunction, finding that Abbott had established a sufficient interest despite a unilateral cease-and-desist declaration, and that the Defendants' GS1 device likely infringed claims 1 and 4 of the patent.
Abbott Diabetes Care Inc. v.Sibio Technology Limited, Umedwings Netherlands B.V.
Abbott Diabetes Care Inc., proprietor of European patent EP 3 831 283 concerning an on-body glucose sensor device, sought provisional measures (a preliminary injunction) against Sibio Technology Limited and Umedwings Netherlands B.V. before the Local Division The Hague. The court denied the application, finding that on the balance of probabilities the patent would more likely than not be held invalid for added matter (Article 123(2) EPC), as claim 1 and its dependent claims extended beyond the disclosure of the original application. Abbott was ordered to bear the defendants' costs, with the value of the dispute set at EUR 4,000,000.
Abbott Diabetes Care Inc. v.Sibio Technology Limited, Umedwings Netherlands B.V.
Abbott Diabetes Care Inc., proprietor of European patent EP 3 831 283 relating to an on-body glucose sensor device, sought provisional measures against Sibio Technology Limited and Umedwings Netherlands B.V. The Court of First Instance of the Unified Patent Court (Local Division The Hague) denied the application, finding that on the balance of probabilities the patent would more likely than not be held invalid for added matter (Article 123(2) EPC). Abbott was ordered to bear the costs of the proceedings, and the value of the dispute was set at EUR 4,000,000.
Abbott Diabetes Care Inc. v.Sibio Technology Limited, Umedwings Netherlands B.V.
Abbott Diabetes Care Inc., proprietor of European patent EP 2 713 879 relating to an apparatus for an on-body continuous glucose monitoring (CGM) sensor device, sought a preliminary injunction against Sibio Technology Limited and Umedwings Netherlands B.V. for allegedly infringing the patent through the marketing of the GS1 CGM device in Europe. The Local Division The Hague granted the preliminary injunction, finding that Abbott had established a sufficient interest and that the Defendants' unilateral cease-and-desist declaration did not render the application devoid of purpose.
10x Genomics, Inc. and President and Fellows of Harvard College v.Vizgen, Inc.
This case before the Local Chamber Hamburg concerned a patent infringement action regarding EP4108782. The defendant Vizgen sought review under Rule 333.1 of an order by the presiding judge that had partially rejected its requests for production of documents disclosed in parallel US proceedings. The full panel granted most of the production requests, ordering the plaintiffs to disclose specific emails, an FAQ document, and a deposition transcript, while treating them as confidential information accessible only to legal counsel.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.